CIK 0001124105
- Accelerated filer
- Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562020050
- Phone
- +1 858-284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-31 | LAWLOR AUGUSTINE Director | Returned to the company | −24.57 | 0 | ||
| 2023-08-31 | LAWLOR AUGUSTINE Director | Returned to the company | −24.22 | 0 | ||
| 2021-10-01 | LAWLOR AUGUSTINE Director | Grant or award | +5,839 | 24,573 | ||
| 2021-07-01 | LAWLOR AUGUSTINE Director | Grant or award | +5,542 | 18,734 | ||
| 2021-06-09 | LAWLOR AUGUSTINE Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2021-04-01 | LAWLOR AUGUSTINE Director | Grant or award | +4,761 | 13,192 | ||
| 2021-01-05 | LAWLOR AUGUSTINE Director | Grant or award | +3,417 | 8,431 | ||
| 2020-10-01 | LAWLOR AUGUSTINE Director | Grant or award | +5,014 | 5,014 | ||
| 2020-07-01 | LAWLOR AUGUSTINE Director | Grant or award | +3,673 | 24,215 | ||
| 2020-06-11 | LAWLOR AUGUSTINE Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2020-04-01 | LAWLOR AUGUSTINE Director | Grant or award | +4,934 | 20,542 | ||
| 2020-02-25 | LAWLOR AUGUSTINE Director | Sale | −69,401 | $6.10 | $424K | 0 |
| 2020-01-02 | LAWLOR AUGUSTINE Director | Grant or award | +3,166 | 15,608 |
Page 1 of 1 · 13 trades